- Report
- October 2025
- 86 Pages
Indonesia
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 87 Pages
Oman
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 96 Pages
Saudi Arabia
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 97 Pages
Qatar
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 91 Pages
Vietnam
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 83 Pages
Vietnam
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 81 Pages
Saudi Arabia
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 88 Pages
Kuwait
From €4245EUR$4,850USD£3,690GBP
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 100 Pages
Saudi Arabia
From €4245EUR$4,850USD£3,690GBP
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 96 Pages
South Korea
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 96 Pages
Japan
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 80 Pages
Germany
From €4245EUR$4,850USD£3,690GBP
- Report
- October 2025
- 80 Pages
Turkey
From €4245EUR$4,850USD£3,690GBP
- Report
- September 2025
- 91 Pages
Poland
From €4245EUR$4,850USD£3,690GBP
- Report
- September 2025
- 97 Pages
Italy
From €4245EUR$4,850USD£3,690GBP
- Report
- September 2025
- 84 Pages
Turkey
From €4245EUR$4,850USD£3,690GBP
- Report
- September 2025
- 88 Pages
United Kingdom
From €4245EUR$4,850USD£3,690GBP
- Report
- June 2025
- 80 Pages
From €3019EUR$3,450USD£2,625GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more